SAN DIEGO -- Patients with Clostridium difficile infection and underlying impaired renal function who were treated with fidaxomicin fared better than those given vancomycin, a researcher said here.

Bile acids, which are altered by bacteria normally living in the large intestine, inhibit the growth of Clostridium difficile, new research indicates. The work sheds light on the ways in which some ...

Study examines hospital transfer structure effect on C. diff: 3 findings Researchers conducted a study to determine the effect of transfers of patients between different hospitals on the rate of ...

COLUMBUS, Ohio - A cluster of factors may help predict which patients are likely to develop Clostridioides difficile, a potentially life-threatening disease commonly known as C. difficile or C. diff, ...

The findings are listed below, starting with the most recent. 1. How machine learning models are rapidly predicting C. diff infections Researchers are developing hospital-specific machine learning ...

C. diff is a type of bacteria that can cause diarrhea, abdominal pain, and tenderness. It is commonly treated with antibiotics such as fidaxomicin (Dificid) and vancomycin (Firvanq). C. diff, short ...